ACB - Aurora Cannabis Reports Strong Q2 2024 Results With Record Positive Adjusted EBITDA | Benzinga
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial and operational results for the second quarter of fiscal year 2024, ending September 30, 2023, revealing a record positive adjusted EBITDA of CAD $3.4 million.
Miguel Martin, CEO of Aurora, stated: "This is our strongest fiscal year to date, led by robust net revenue growth in our high-margin medical cannabis segment, coupled with positive adjusted EBITDA for the fourth consecutive quarter."
See Also: Aurora Cannabis Takes Bold Step Towards Financial Recovery
Second Quarter 2024 Financial Highlights
- Consolidated Revenue and Adjusted Gross Profit: The company reported a 30% year-over-year increase in quarterly net revenue, reaching ...